ACR Meeting Abstracts

ACR Meeting Abstracts

  • Meetings
    • ACR Convergence 2024
    • ACR Convergence 2023
    • 2023 ACR/ARP PRSYM
    • ACR Convergence 2022
    • ACR Convergence 2021
    • ACR Convergence 2020
    • 2020 ACR/ARP PRSYM
    • 2019 ACR/ARP Annual Meeting
    • 2018-2009 Meetings
    • Download Abstracts
  • Keyword Index
  • Advanced Search
  • Your Favorites
    • Favorites
    • Login
    • View and print all favorites
    • Clear all your favorites
  • ACR Meetings

Abstract Number: 0946

Distinct Lipidomic Signatures in Synovium and Synovial Fluid of Patients with Rheumatoid Arthritis versus Psoriatic Arthritis

Beatriz Rocha1, Berta Cillero-Pastor2, Anna Illiano3, Valentina Calamia1, Gabriella Pinto4, Angela Amoresano4, Cristina Ruiz-Romero5, Juan D Cañete6, Ron MA Heeren2 and Francisco Blanco-García7, 1Unidad de Proteómica. Grupo de Investigación de Reumatología (GIR). Instituto de Investigación Biomédica de A Coruña (INIBIC), Complexo Hospitalario Universitario de A Coruña (CHUAC), Sergas. Universidade da Coruña (UDC). C/ As Xubias de Arriba 84, 15006 A Coruña, España., A Coruña, Spain, 2The Maastricht Multimodal Molecular Imaging Institute (M4I), Division of Imaging Mass Spectrometry, Maastricht University, The Netherlands., Maastricht, Netherlands, 3CEINGE - Advanced Biotecnology, 80145 Napoli, Italy. Instituto Nazionale Biostrutture e Biosistemi (INBB), Rome, Italy., Naples, Italy, 4Department of Chemical Sciences, University of Naples “Federico II”, Napoli, Italy. Instituto Nazionale Biostrutture e Biosistemi (INBB), Rome, Italy, 5Unidad de Proteómica. Grupo de Investigación de Reumatología (GIR). Instituto de Investigación Biomédica de A Coruña (INIBIC), Complexo Hospitalario Universitario de A Coruña (CHUAC), Sergas. Universidade da Coruña (UDC). C/ As Xubias de Arriba 84, 15006, A Coruña, España.Centro de Investigación Biomédica en Red de Bioingeniería, Biomateriales y Nanomedicina (CIBER-BBN). Av. Monforte de Lemos, 3-5. Pabellón 11, 28029, Madrid, España., A Coruña, Spain, 6Rheumatology Department, Hospital Clinic, Barcelona, Spain, 7Unidad de Proteómica. Grupo de Investigación de Reumatología (GIR). Instituto de Investigación Biomédica de A Coruña (INIBIC), Complexo Hospitalario Universitario de A Coruña (CHUAC), Sergas. Universidade da Coruña (UDC). C/ As Xubias de Arriba 84, 15006, A Coruña, España.Universidade da Coruña (UDC), Grupo de Investigación de Reumatología y Salud (GIR-S). Departamento de Fisioterapia, Medicina y Ciencias Biomédicas, Facultad de Fisioterapia, Campus de Oza, 15008, A Coruña, España., A Coruña, Spain

Meeting: ACR Convergence 2021

Keywords: Diagnostic criteria, lipidomics, Psoriatic arthritis, rheumatoid arthritis, synovial

  • Tweet
  • Click to email a link to a friend (Opens in new window) Email
  • Click to print (Opens in new window) Print
Session Information

Date: Sunday, November 7, 2021

Title: Abstracts: Spondyloarthritis Including PsA – Basic Science (0944–0947)

Session Type: Abstract Session

Session Time: 9:30AM-9:45AM

Background/Purpose: The differential diagnosis of Rheumatoid Arthritis (RA) and Psoriatic arthritis (PsA) is often difficult due to the similarity of symptoms and the unavailability of reliable clinical biomarkers. Lipid alterations have been suggested to contribute to the pathophysiological processes in the knee joint, and chronic inflammation induces significant changes in the synovium and synovial fluid (SF) lipidome. Therefore, we aimed to evaluate whether differences in the lipid profiles from synovial membrane (SM) and SF could support the differential diagnosis of these diseases.

Methods: SM samples of patients affected by RA (n=6), PsA (n=12) and control donors (n=10) were compared using Matrix-Assisted Laser Desorption Ionization Mass Spectrometry Imaging (MALDI-MSI) for spatially resolved lipid analysis. To this end, tissue sections were measured on a RapifleX MALDI-TOF/TOF instrument. Next, a targeted approach based on multiple reaction monitoring (MRM-MS) was performed to further validate the lipidomic alterations reported by MALDI-MSI between RA and PsA tissues. In this case, lipids extracted from SF (control donors (n=4), RA (n=21) and PsA (n=27)) were analyzed in a QTRAP 4000 mass spectrometer coupled with an ExpressHT™-Ultra HPLC system for the targeted analysis of 84 lipid species. Principal component analysis (PCA) and discriminant analysis (DA) were used for data interpretation.

Results: Lipid profiles of PsA and RA synovial membranes were unequivocally distinguished by MALDI-MSI followed by PCA-DA. Interestingly, several lipid species, including sphingomyelins, phosphatidylcholines (PC) and phosphatidylethanolamines (PE), presented the greatest separation power to classify RA and PsA tissue samples. On the other hand, the lipid profile of arthritic SM samples was also discriminated from control tissues. Specifically, several lysophosphatidylcholines showed the greatest discriminative capability for separating groups. The abundance of those lipid species with discriminatory potential were further compared using ANOVA. This analysis found 35 lipid species significantly different among the study groups, where most of them were significantly increased in RA and PsA compared to controls. Particularly, 11 lipids showed higher levels in PsA tissues compared with RA, including several PC and PE such as PE 34:1 and PE 36:1. The spatial distribution of these PE species was associated with areas of the sublining layer with increased vascularity and inflammatory cell infiltrates, according to MALDI-MSI images. On the other hand, RA and PsA patients were also correctly classified based on the SF levels of all quantified lipid species according to PCA and clustering analysis. Finally, we were able to validate the increased levels of PE 34:1 and PE 36:1 in the SF of PsA patients compared to RA (Figure 1).

Conclusion: Our study shows a distinct lipid profile between RA and PsA synovium and synovial fluid, and reports potential clinically useful lipid markers for the differential diagnosis of these diseases.

Figure 1. Increased levels of PE 34:1 and PE 36:1 in the PsA synovium and synovial fluid compared to RA. A) Images show samples from two representative RA and PsA biopsies stained with hematoxylin and eosin. B) MALDI-MSI images showing the differences in the abundance and spatial distribution of PE 34:1 and PE 36:1 in PsA synovium compared to RA samples. The colour scale at the bottom left indicates the relative abundance. Pink or white denote higher abundances, while blue or black denote lower abundances. C) SF levels of PE 34:1 and PE 36:1 are increased in PsA patients compared to RA. Y-axis represents concentrations in pg/µl. **p-value < 0.01. PE, phosphatidylethanolamine; RA, rheumatoid arthritis; PsA, psoriatic arthritis; SF, synovial fluid.


Disclosures: B. Rocha, None; B. Cillero-Pastor, None; A. Illiano, None; V. Calamia, None; G. Pinto, None; A. Amoresano, None; C. Ruiz-Romero, None; J. Cañete, Abbvie, 6, Pfizer, 6, Janssen, 6; R. Heeren, None; F. Blanco-García, None.

To cite this abstract in AMA style:

Rocha B, Cillero-Pastor B, Illiano A, Calamia V, Pinto G, Amoresano A, Ruiz-Romero C, Cañete J, Heeren R, Blanco-García F. Distinct Lipidomic Signatures in Synovium and Synovial Fluid of Patients with Rheumatoid Arthritis versus Psoriatic Arthritis [abstract]. Arthritis Rheumatol. 2021; 73 (suppl 9). https://acrabstracts.org/abstract/distinct-lipidomic-signatures-in-synovium-and-synovial-fluid-of-patients-with-rheumatoid-arthritis-versus-psoriatic-arthritis/. Accessed .
  • Tweet
  • Click to email a link to a friend (Opens in new window) Email
  • Click to print (Opens in new window) Print

« Back to ACR Convergence 2021

ACR Meeting Abstracts - https://acrabstracts.org/abstract/distinct-lipidomic-signatures-in-synovium-and-synovial-fluid-of-patients-with-rheumatoid-arthritis-versus-psoriatic-arthritis/

Advanced Search

Your Favorites

You can save and print a list of your favorite abstracts during your browser session by clicking the “Favorite” button at the bottom of any abstract. View your favorites »

All abstracts accepted to ACR Convergence are under media embargo once the ACR has notified presenters of their abstract’s acceptance. They may be presented at other meetings or published as manuscripts after this time but should not be discussed in non-scholarly venues or outlets. The following embargo policies are strictly enforced by the ACR.

Accepted abstracts are made available to the public online in advance of the meeting and are published in a special online supplement of our scientific journal, Arthritis & Rheumatology. Information contained in those abstracts may not be released until the abstracts appear online. In an exception to the media embargo, academic institutions, private organizations, and companies with products whose value may be influenced by information contained in an abstract may issue a press release to coincide with the availability of an ACR abstract on the ACR website. However, the ACR continues to require that information that goes beyond that contained in the abstract (e.g., discussion of the abstract done as part of editorial news coverage) is under media embargo until 10:00 AM ET on November 14, 2024. Journalists with access to embargoed information cannot release articles or editorial news coverage before this time. Editorial news coverage is considered original articles/videos developed by employed journalists to report facts, commentary, and subject matter expert quotes in a narrative form using a variety of sources (e.g., research, announcements, press releases, events, etc.).

Violation of this policy may result in the abstract being withdrawn from the meeting and other measures deemed appropriate. Authors are responsible for notifying colleagues, institutions, communications firms, and all other stakeholders related to the development or promotion of the abstract about this policy. If you have questions about the ACR abstract embargo policy, please contact ACR abstracts staff at [email protected].

Wiley

  • Online Journal
  • Privacy Policy
  • Permissions Policies
  • Cookie Preferences

© Copyright 2025 American College of Rheumatology